CIK 0001725160
- Non-accelerated filer
- Smaller reporting company
Zentalis Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ZNTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 823607803
- Phone
- +1 858-263-4333
- Business address
- 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 24 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-19 | Voliotis Dimitris SVP, Clinical Development | Exercise or conversion | +10,000 | $18.00 | $180K | 16,250 |
| 2022-01-19 | Voliotis Dimitris SVP, Clinical Development | Sale | −7,889 | $60.55 | $478K | 8,361 |
| 2022-01-19 | Voliotis Dimitris SVP, Clinical Development | Sale | −1,556 | $61.51 | $96K | 6,805 |
| 2022-01-19 | Voliotis Dimitris SVP, Clinical Development | Sale | −555 | $62.24 | $35K | 6,250 |
| 2022-01-19 | Voliotis Dimitris SVP, Clinical Development | Exercise or conversion · Stock Option | −10,000 | 134,949 | ||
| 2022-01-18 | Voliotis Dimitris SVP, Clinical Development | Exercise or conversion | +10,000 | $18.00 | $180K | 16,250 |
| 2022-01-18 | Voliotis Dimitris SVP, Clinical Development | Sale | −3,409 | $61.70 | $210K | 12,841 |
| 2022-01-18 | Voliotis Dimitris SVP, Clinical Development | Sale | −3,294 | $62.34 | $205K | 9,547 |
| 2022-01-18 | Voliotis Dimitris SVP, Clinical Development | Sale | −1,997 | $63.48 | $127K | 7,550 |
| 2022-01-18 | Voliotis Dimitris SVP, Clinical Development | Sale | −1,300 | $64.66 | $84K | 6,250 |
| 2022-01-18 | Voliotis Dimitris SVP, Clinical Development | Exercise or conversion · Stock Option | −10,000 | 144,949 | ||
| 2022-01-18 | Gallagher Cam Director | Sale | −3,434 | $61.71 | $212K | 403,769 |
| 2022-01-18 | Gallagher Cam Director | Sale | −3,424 | $62.37 | $214K | 400,345 |
| 2022-01-18 | Gallagher Cam Director | Sale | −1,842 | $63.45 | $117K | 398,503 |
| 2022-01-18 | Gallagher Cam Director | Sale | −1,300 | $64.66 | $84K | 397,203 |
| 2022-01-10 | Bunker Kevin D. Chief Operating Officer | Sale | −3,146 | $67.24 | $212K | 196,854 |
| 2022-01-10 | Bunker Kevin D. Chief Operating Officer | Sale | −2,807 | $68.05 | $191K | 194,047 |
| 2022-01-10 | Bunker Kevin D. Chief Operating Officer | Sale | −1,835 | $69.03 | $127K | 192,212 |
| 2022-01-10 | Bunker Kevin D. Chief Operating Officer | Sale | −2,212 | $70.02 | $155K | 190,000 |
| 2022-01-05 | Gallagher Cam Director | Sale | −2,397 | $73.18 | $175K | 414,806 |
Page 13 of 28 · 545 trades